Medifron DBT Co Ltd
KOSDAQ:065650
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Medifron DBT Co Ltd
Cash Interest Paid
Medifron DBT Co Ltd
Cash Interest Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Medifron DBT Co Ltd
KOSDAQ:065650
|
Cash Interest Paid
₩205.7m
|
CAGR 3-Years
121%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
21%
|
|
|
M
|
Makus Inc
KOSDAQ:093520
|
Cash Interest Paid
₩1.2B
|
CAGR 3-Years
188%
|
CAGR 5-Years
50%
|
CAGR 10-Years
20%
|
|
|
S
|
SAMT Co Ltd
KOSDAQ:031330
|
Cash Interest Paid
₩14.8B
|
CAGR 3-Years
36%
|
CAGR 5-Years
62%
|
CAGR 10-Years
10%
|
|
|
D
|
Dmoa Co Ltd
KOSDAQ:016670
|
Cash Interest Paid
₩96.9m
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
11%
|
|
|
S
|
STCube Inc
KOSDAQ:052020
|
Cash Interest Paid
₩339.3m
|
CAGR 3-Years
34%
|
CAGR 5-Years
24%
|
CAGR 10-Years
33%
|
|
|
U
|
Unitron Tech Co Ltd
KOSDAQ:142210
|
Cash Interest Paid
₩7.2B
|
CAGR 3-Years
34%
|
CAGR 5-Years
39%
|
CAGR 10-Years
30%
|
|
Medifron DBT Co Ltd
Glance View
Medifron DBT Co., Ltd. engages in the provision of information technology (IT) content services. The company is headquartered in Seoul, Seoul and currently employs 55 full-time employees. The company went IPO on 2003-01-21. The firm operates its business through two segments. The Information Technology Business segment is involved in the manufacturing and sale of mouses, monitors, televisions (TVs), routers and game devices. In addition, it is involved in the operation of Internet portals and specialized sites. The New Drug Business segment is engaged in the development and sale of non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits.
See Also
What is Medifron DBT Co Ltd's Cash Interest Paid?
Cash Interest Paid
205.7m
KRW
Based on the financial report for Sep 30, 2025, Medifron DBT Co Ltd's Cash Interest Paid amounts to 205.7m KRW.
What is Medifron DBT Co Ltd's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 10Y
21%
The average annual Cash Interest Paid growth rates for Medifron DBT Co Ltd have been 121% over the past three years , and 21% over the past ten years .
